Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.

Wuthrich RP; Weinreich T; Schwarzkopf AK; Candinas D; Binswanger U

首页> 外文期刊>Transplantation Proceedings >Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.

【24h】

Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.

机译：与传统的基于硫唑嘌呤的方案相比，基于霉酚酸酯的三联疗法免疫抑制的上市后评估显示肾移植后疗效增强，并在早期获得了药物经济学上的收益。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transplantation Proceedings》 |1998年第8期|共2页
作者
Wuthrich RP; Weinreich T; Schwarzkopf AK; Candinas D; Binswanger U;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科手术学;
关键词
Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; RS-61443; 免疫抑制剂; 肾移植; 霉酚酸;

机译：Immunosuppressive Agents;Kidney Transplantation;Mycophenolic Acid;RS-61443;免疫抑制剂;肾移植;霉酚酸;

相似文献

外文文献
中文文献

1. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation. [J] . Wuthrich RP, Weinreich T, Schwarzkopf AK, Transplantation Proceedings . 1998,第8期

机译：与传统的基于硫唑嘌呤的方案相比，基于霉酚酸酯的三联疗法免疫抑制的上市后评估显示肾移植后疗效增强，并在早期获得了药物经济学上的收益。
2. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols. [J] . Attallah N, Goggins M, Nori U, Transplantation Proceedings . 2005,第5期

机译：在霉酚酸酯和基于硫唑嘌呤的三联药物免疫抑制方案中长期实际肾脏同种异体移植存活率的比较。
3. Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients. [J] . Zanker B, ol.com, Schneeberger H, Transplantation: Official Journal of the Transplantation Society . 1998,第1期

机译：基于麦考酚酸酯的，无环孢素的诱导和维持免疫抑制：两个肾移植受者队列的前三个月的疗效和安全性分析。
4. Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients [O] . Lena Caroline Brunkhorst, Alexander Fichtner, Britta Höcker, -1

机译：依维莫司与基于麦考酚酸酯的儿科肾移植受治者的疗效和安全性
5. Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients. [O] . Lena Caroline Brunkhorst, Alexander Fichtner, Britta Höcker, 2015

机译：依维莫司 - 与霉酚酸酯基于mofetil的方案在小儿肾移植受者中的功效和安全性。

Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.

著录项

相似文献

相关主题

期刊订阅